National Research (NASDAQ:NRC - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.25 EPS for the quarter, Zacks reports. National Research had a return on equity of 66.52% and a net margin of 17.32%. The company had revenue of $33.55 million for the quarter.
National Research Price Performance
Shares of NRC traded up $0.21 during mid-day trading on Friday, hitting $12.33. The company's stock had a trading volume of 6,773 shares, compared to its average volume of 94,409. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The firm has a 50-day moving average price of $12.96 and a 200 day moving average price of $16.35. National Research has a fifty-two week low of $9.76 and a fifty-two week high of $35.81. The stock has a market capitalization of $282.81 million, a price-to-earnings ratio of 11.79 and a beta of 0.41.
National Research Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.89%. The ex-dividend date is Friday, June 27th. National Research's payout ratio is 45.71%.
About National Research
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Articles
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
